Please see the following information from NIH:
- Notice of Fiscal Policies in Effect for FY 2022 (NOT-OD-22-105) National Institutes of Health
- This Notice provides guidance about the NIH Fiscal Operations for Fiscal Year 2022 and implements the Consolidated Appropriations Act, 2022 (Public Law 117-103), signed into law on March 15, 2022.
- FY 2022 Funding Levels: Non-competing continuation awards made in FY 2022 will generally be issued at the commitment level indicated on the Notice of Award. Any exceptions will be posted at the site listed under “Additional Information”, below. Subsequent budget periods are funded based on the availability of appropriations, satisfactory performance, compliance with the terms and conditions of the award, and the continued best interest of the Federal government. The NIH awarding Institutes/Centers (ICs) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2022 funds.
- Ruth L. Kirschstein National Research Service Awards (NRSA): Consistent with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, the NIH will increase NRSA stipends by approximately two percent for predocs and two percent for postdocs. The full range of stipend adjustments for FY 2022 is described in NIH Guide Notice NOT-OD-22-108.
- Salary Limits: Section 747 of PL 117-103 restricts the amount of direct salary to Executive Level II of the Federal Executive pay scale. Effective January 2, 2022, the salary limitation for Executive Level II is $203,700. Further information is described in NIH Guide Notice NOT-OD-22-076.
- Additional Information: Additional details on Fiscal Operations, including specific funding strategies for ICs, will be posted on the NIH Funding Strategies webpage.
Last Updated on April 19, 2022